134 related articles for article (PubMed ID: 37408506)
1. Ex vivo mapping of enhancer networks that define the transcriptional program driving melanoma metastasis.
Manicardi V; Gugnoni M; Sauta E; Donati B; Vitale E; Torricelli F; Manzotti G; Piana S; Longo C; Ghini F; Ciarrocchi A
Mol Oncol; 2023 Dec; 17(12):2728-2742. PubMed ID: 37408506
[TBL] [Abstract][Full Text] [Related]
2. MEK inhibition remodels the active chromatin landscape and induces SOX10 genomic recruitment in BRAF(V600E) mutant melanoma cells.
Fufa TD; Baxter LL; Wedel JC; Gildea DE; ; Loftus SK; Pavan WJ
Epigenetics Chromatin; 2019 Aug; 12(1):50. PubMed ID: 31399133
[TBL] [Abstract][Full Text] [Related]
3. No Need to Stick Together to Be Connected: Multiple Types of Enhancers' Networking.
Vitale E; Gugnoni M; Ciarrocchi A
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680347
[TBL] [Abstract][Full Text] [Related]
4. A dynamic H3K27ac signature identifies VEGFA-stimulated endothelial enhancers and requires EP300 activity.
Zhang B; Day DS; Ho JW; Song L; Cao J; Christodoulou D; Seidman JG; Crawford GE; Park PJ; Pu WT
Genome Res; 2013 Jun; 23(6):917-27. PubMed ID: 23547170
[TBL] [Abstract][Full Text] [Related]
5. RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN.
Sancisi V; Manzotti G; Gugnoni M; Rossi T; Gandolfi G; Gobbi G; Torricelli F; Catellani F; Faria do Valle I; Remondini D; Castellani G; Ragazzi M; Piana S; Ciarrocchi A
Nucleic Acids Res; 2017 Nov; 45(19):11249-11267. PubMed ID: 28981843
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide prediction of conserved and nonconserved enhancers by histone acetylation patterns.
Roh TY; Wei G; Farrell CM; Zhao K
Genome Res; 2007 Jan; 17(1):74-81. PubMed ID: 17135569
[TBL] [Abstract][Full Text] [Related]
7. Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis.
de Souza CF; Xander P; Monteiro AC; Silva AG; da Silva DC; Mai S; Bernardo V; Lopes JD; Jasiulionis MG
PLoS One; 2012; 7(9):e44800. PubMed ID: 22984562
[TBL] [Abstract][Full Text] [Related]
8. A UTX-MLL4-p300 Transcriptional Regulatory Network Coordinately Shapes Active Enhancer Landscapes for Eliciting Transcription.
Wang SP; Tang Z; Chen CW; Shimada M; Koche RP; Wang LH; Nakadai T; Chramiec A; Krivtsov AV; Armstrong SA; Roeder RG
Mol Cell; 2017 Jul; 67(2):308-321.e6. PubMed ID: 28732206
[TBL] [Abstract][Full Text] [Related]
9. A 3' enhancer controls snail expression in melanoma cells.
Palmer MB; Majumder P; Green MR; Wade PA; Boss JM
Cancer Res; 2007 Jul; 67(13):6113-20. PubMed ID: 17616667
[TBL] [Abstract][Full Text] [Related]
10. Chromatin state signatures associated with tissue-specific gene expression and enhancer activity in the embryonic limb.
Cotney J; Leng J; Oh S; DeMare LE; Reilly SK; Gerstein MB; Noonan JP
Genome Res; 2012 Jun; 22(6):1069-80. PubMed ID: 22421546
[TBL] [Abstract][Full Text] [Related]
11. Network assessment of demethylation treatment in melanoma: Differential transcriptome-methylome and antigen profile signatures.
Jiang Z; Cinti C; Taranta M; Mattioli E; Schena E; Singh S; Khurana R; Lattanzi G; Tsinoremas NF; Capobianco E
PLoS One; 2018; 13(11):e0206686. PubMed ID: 30485296
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide mapping of transcriptional enhancer candidates using DNA and chromatin features in maize.
Oka R; Zicola J; Weber B; Anderson SN; Hodgman C; Gent JI; Wesselink JJ; Springer NM; Hoefsloot HCJ; Turck F; Stam M
Genome Biol; 2017 Jul; 18(1):137. PubMed ID: 28732548
[TBL] [Abstract][Full Text] [Related]
13. Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state.
Verfaillie A; Imrichova H; Atak ZK; Dewaele M; Rambow F; Hulselmans G; Christiaens V; Svetlichnyy D; Luciani F; Van den Mooter L; Claerhout S; Fiers M; Journe F; Ghanem GE; Herrmann C; Halder G; Marine JC; Aerts S
Nat Commun; 2015 Apr; 6():6683. PubMed ID: 25865119
[TBL] [Abstract][Full Text] [Related]
14. Establishment of regulatory elements during erythro-megakaryopoiesis identifies hematopoietic lineage-commitment points.
Heuston EF; Keller CA; Lichtenberg J; Giardine B; Anderson SM; ; Hardison RC; Bodine DM
Epigenetics Chromatin; 2018 May; 11(1):22. PubMed ID: 29807547
[TBL] [Abstract][Full Text] [Related]
15. Global analysis of histone modifications and long-range chromatin interactions revealed the differential cistrome changes and novel transcriptional players in human dilated cardiomyopathy.
Liu CF; Abnousi A; Bazeley P; Ni Y; Morley M; Moravec CS; Hu M; Tang WHW
J Mol Cell Cardiol; 2020 Aug; 145():30-42. PubMed ID: 32533974
[TBL] [Abstract][Full Text] [Related]
16. Identification of cis regulatory features in the embryonic zebrafish genome through large-scale profiling of H3K4me1 and H3K4me3 binding sites.
Aday AW; Zhu LJ; Lakshmanan A; Wang J; Lawson ND
Dev Biol; 2011 Sep; 357(2):450-62. PubMed ID: 21435340
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic epigenetic state of primary osteosarcoma drives metastasis.
Singh I; Rainusso N; Kurenbekova L; Nirala BK; Dou J; Muruganandham A; Yustein JT
bioRxiv; 2023 Nov; ():. PubMed ID: 38014160
[TBL] [Abstract][Full Text] [Related]
18. Increased chromatin plasticity supports enhanced metastatic potential of mouse melanoma cells.
Maizels Y; Elbaz A; Hernandez-Vicens R; Sandrusy O; Rosenberg A; Gerlitz G
Exp Cell Res; 2017 Aug; 357(2):282-290. PubMed ID: 28551377
[TBL] [Abstract][Full Text] [Related]
19. Comparative analyses of super-enhancers reveal conserved elements in vertebrate genomes.
Pérez-Rico YA; Boeva V; Mallory AC; Bitetti A; Majello S; Barillot E; Shkumatava A
Genome Res; 2017 Feb; 27(2):259-268. PubMed ID: 27965291
[TBL] [Abstract][Full Text] [Related]
20. Epigenomic landscape of melanoma progression to brain metastasis: unexplored therapeutic alternatives.
Marzese DM; Witz IP; Kelly DF; Hoon DS
Epigenomics; 2015; 7(8):1303-11. PubMed ID: 26638944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
